Jane Street Group, LLC G1 Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.2 - $4.98 $591,043 - $1.34 Million	-268,656 Reduced 80.54%	64,916 $148,000
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $233,041 - $535,994	110,972 Added 49.85%	333,572 $1.44 Million
Q4 2023 Feb 14, 2024	BUY	$1.12 - $3.73 $237,669 - $791,524	212,205 Added 2041.41%	222,600 $678,000
Q3 2023 Nov 14, 2023	BUY	$1.22 - $2.67 $12,681 - $27,754	10,395 New	10,395 $14,000
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $195,535 - $620,845	-76,084 Reduced 57.59%	56,040 $150,000
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $262,074 - $681,696	50,496 Added 61.86%	132,124 $717,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $301,840 - $991,927	58,383 Added 251.16%	81,628 $1.02 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $301,840 - $991,927	58,383 Added 251.16%	81,628 $1.02 Million
Q2 2022 Aug 16, 2022	SELL	$4.04 - $8.51 $50,863 - $107,140	-12,590 Reduced 35.13%	23,245 $115,000
Q1 2022 May 17, 2022	SELL	$7.6 - $11.02 $108,087 - $156,726	-14,222 Reduced 28.41%	35,835 $272,000
Q4 2021 Feb 15, 2022	SELL	$10.16 - $16.17 $150,164 - $238,992	-14,780 Reduced 22.8%	50,057 $511,000
Q3 2021 Nov 16, 2021	BUY	$13.16 - $22.47 $331,447 - $565,929	25,186 Added 63.52%	64,837 $870,000
Q2 2021 Aug 16, 2021	SELL	$19.57 - $26.32 $1.57 Million - $2.11 Million	-80,000 Reduced 66.86%	39,651 $870,000
Q1 2021 May 18, 2021	BUY	$17.58 - $32.59 $1.64 Million - $3.03 Million	93,056 Added 349.9%	119,651 $2.88 Million
Q4 2020 Feb 17, 2021	BUY	$10.99 - $20.4 $57,906 - $107,487	5,269 Added 24.71%	26,595 $478,000
Q3 2020 Nov 17, 2020	BUY	$11.55 - $23.75 $246,315 - $506,492	21,326 New	21,326 $247,000
Q4 2019 Feb 14, 2020	SELL	$20.54 - $31.0 $284,417 - $429,257	-13,847 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$22.78 - $40.58 $315,434 - $561,911	13,847 New	13,847 $315,000
Q4 2018 Feb 15, 2019	SELL	$16.51 - $51.33 $236,291 - $734,634	-14,312 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $617,562 - $972,786	14,312 New	14,312 $748,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account